Capitolis Liquid Global Markets’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Capitolis Liquid Global Markets's PFE Position: Q2 2026 in Review
Capitolis Liquid Global Markets reduced its Pfizer (PFE) stake by 82% in Q2 2026, selling an estimated $5.37M and leaving 43,700 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #306.
Capitolis Liquid Global Markets first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $39.5M in Q3 2025. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Capitolis Liquid Global Markets held 43,700 shares of Pfizer worth $1.05M as of Q2 2026.
- Capitolis Liquid Global Markets sold 205,271 Pfizer shares in Q2 2026, an estimated $5.37M.
- Pfizer made up ﹤0.01% of Capitolis Liquid Global Markets's portfolio in Q2 2026, its #306 holding.
- Capitolis Liquid Global Markets first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
- Capitolis Liquid Global Markets's Pfizer position peaked at $39.5M in Q3 2025.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Capitolis Liquid Global Markets's 13F filing for Q2 2026, filed 13 Aug 2026.